Indivior PLC (INDV) Investigation: Bronstein, Gewirtz &

NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) — Attorney Advertising – Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC (“Indivior” or “the Company”) (NASDAQ: INDV). Investors who purchased securities of Indivior are encouraged to obtain additional information and assist in the investigation by visiting the Company’s website: bgandg.com/INDV.

Examination details

On July 9, 2024, Indivior issued a press release announcing “a business update that includes financial performance for the second quarter and fiscal year 2024.” Among other things, Indivior lowered its fiscal year 2024 financial guidance, citing, among other things, sales hurdles related to Sublocate, a prescription drug used to treat opioid use disorder. Indivior also announced the decision to discontinue its schizophrenia drug Perseris, a move the company said would reduce its headcount by approximately 130 employees. Following this news, Indivior’s stock price fell $5.15 per share, or 33.57%, closing at $10.19 per share on July 9, 2024.

What’s next?

If you are aware of facts related to this investigation, or if you purchased securities of Indivior, you may assist this investigation by visiting the firm’s website at bgandg.com/INDV. You may also contact Peretz Bronstein or his account executive Nathan Miller of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.

There are no costs for you

We represent investors in class action lawsuits on a contingency basis, meaning we only ask the court to reimburse us for our expenses and attorneys’ fees (typically a percentage of the total award) if we win.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized law firm representing investors in securities fraud class action lawsuits and shareholder actions involving derivatives trading. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Past results do not guarantee similar results.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | [email protected]